KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Prepaid Assets: 2017-2025

Historic Prepaid Assets for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to $716.0 million.

  • Moderna's Prepaid Assets fell 13.00% to $716.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $716.0 million, marking a year-over-year decrease of 13.00%. This contributed to the annual value of $599.0 million for FY2024, which is 4.47% down from last year.
  • According to the latest figures from Q3 2025, Moderna's Prepaid Assets is $716.0 million, which was down 6.28% from $764.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Prepaid Assets ranged from a high of $1.4 billion in Q1 2023 and a low of $264.0 million during Q1 2021.
  • Its 3-year average for Prepaid Assets is $799.1 million, with a median of $716.0 million in 2025.
  • Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 1,004.46% in 2021, then tumbled by 52.36% in 2024.
  • Quarterly analysis of 5 years shows Moderna's Prepaid Assets stood at $728.0 million in 2021, then surged by 64.15% to $1.2 billion in 2022, then plummeted by 47.53% to $627.0 million in 2023, then decreased by 4.47% to $599.0 million in 2024, then fell by 13.00% to $716.0 million in 2025.
  • Its Prepaid Assets stands at $716.0 million for Q3 2025, versus $764.0 million for Q2 2025 and $585.0 million for Q1 2025.